Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Novo Nordisk wants to bring an oral version of Wegovy to South Africa. The timing has a lot to do with logistics, not just medicine. The Danish drugmaker says the pill form of its weight-loss treatment could work especially well…
The rivalry between the two biggest names in weight loss medicine just moved into a federal courtroom. Novo Nordisk filed a lawsuit against Eli Lilly on July 21, 2026. The company filed it in the U.S. District Court for the…
Samsung Biologics wants a piece of the GLP-1 boom. The Korean manufacturing giant has offered to buy PolyPeptide, a Swiss peptide manufacturer, in an all-cash deal worth about $1.8 billion. Under the terms, PolyPeptide shareholders will receive CHF 44.31 per…
Burger King is already thinking ahead. The company wants to prepare for a future where weight loss drugs change how Americans eat. Tom Curtis runs the chain’s U.S. and Canada business. He laid out the strategy in a recent interview…
Have you ever tried to help an overweight cat slim down? It’s not easy. You can’t take a cat jogging. Diet changes often meet stubborn resistance. And most cats simply refuse a consistent medication schedule. Now two U.S. biotech companies…
Weight management just got simpler in Europe. The European Commission has approved a once-daily tablet form of semaglutide, the same ingredient found in Ozempic and Wegovy, for adults with obesity or excess weight. It’s the first oral option of its…
A new study is raising concerns about the mental health of type 2 diabetes patients who stop taking GLP-1 receptor agonist drugs. Until now, doctors haven’t had much information about how stopping these medications affects patients psychologically. To find out…
Tom Brady is stepping into a new role. It’s not on the football field this time. The NFL legend now serves as chief wellness officer at eMed, a digital health company. Their mission: get GLP-1 weight loss medications into the…
A 63-year-old woman in Massachusetts landed in the emergency room with abdominal pain that wouldn’t quit. The eventual fix wasn’t surgery. It wasn’t a new drug either. Instead, doctors turned to Diet Coke, about 1.5 liters a day. Her case…
New research suggests something surprising about GLP-1 drugs like Ozempic and Wegovy. Their effects might reach far beyond the scale. A working paper from the National Bureau of Economic Research found something notable. Women who lost weight on these medications…